Loss of Pulse Detection vs Irregular Rhythm Notification Feature (IRNF)

Both tools are designed for over-the-counter use and integrate with their respective mobile ecosystems (Fitbit/Google Health app and Apple Health app). Both require an onboarding process to educate users. While Fitbit's Loss of Pulse Detection offers automatic emergency calling, Apple's IRNF focuses on notifications for user-physician discussion. Both aim for ease of use within their established wearable platforms.

Fitbit's Loss of Pulse Detection offers a more immediate and potentially life-saving intervention by automatically alerting emergency services if the user is unresponsive after a detected loss of pulse. While Apple's IRNF provides valuable early detection of potential AFib, it requires user action to consult a physician and does not offer direct emergency intervention. Both are FDA-cleared and have undergone clinical validation.

Apple's Irregular Rhythm Notification Feature is included with the purchase of an Apple Watch, offering its functionality without an additional subscription cost. Fitbit's Loss of Pulse Detection is included with compatible devices like the Pixel Watch 3, but some advanced health tracking features on Fitbit devices may require a Google Health Premium subscription.

Fitbit (now Google Health) explicitly offers 'Google Health Enterprise' solutions for organizations, including employer solutions, Medicare Advantage plans, and care solutions, indicating a clear focus on enterprise integration and population health management. Fitbit also offers a Business Associate Agreement (BAA). Apple does not offer a BAA for IRNF as a standalone product or for HealthKit data for individual apps, which may limit its direct enterprise adoption in certain healthcare contexts.

Fitbit's Loss of Pulse Detection represents a significant innovation by integrating accelerometry with PPG to detect a loss of pulse and automatically initiate emergency services if the user is unresponsive. This proactive, automated emergency response is a novel step in consumer wearables. While Apple's IRNF 2.0 uses machine learning for improved AFib differentiation, the core functionality of irregular rhythm detection has been available for some time.

Both companies provide extensive support and documentation for their features. Apple offers detailed instructions for use, support articles, and information within the Health app. Fitbit, as part of Google, also provides user manuals, help communities, and direct support through its platforms. Both are well-established consumer technology companies with robust support infrastructures.